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Signal transducer and activator of transcription 1 (STAT1) plays a pivotal role in the 30 
innate immune system by directing the transcriptional response to interferons (IFN). 31 
Stat1 is activated by Janus kinase (JAK)-mediated phosphorylation of Y701. To 32 
determine whether STAT1 contributes to cellular responses without this phosphorylation 33 
event, we generated mice with Y701 mutated to a phenylalanine (Stat1Y701F). We show that 34 
heterozygous mice do not exhibit a dominant negative phenotype. Homozygous 35 
Stat1Y701F mice show a profound reduction in Stat1 expression, highlighting an important 36 
role for basal IFN-dependent signaling. The rapid transcriptional response to type I IFN 37 
(IFN-I) and type II IFN (IFNγ) was absent in Stat1Y701F cells. Intriguingly, STAT1Y701F 38 
suppresses the delayed expression of IFN-I-stimulated genes (ISG) observed in Stat1-/- 39 
cells, mediated by the STAT2- IRF9 complex. Thus, Stat1Y701F macrophages are more 40 
susceptible to Legionella pneumophila infection than Stat1-/- macrophages. Listeria 41 
moncytogenes grew less robustly in Stat1Y701F macrophages and mice compared to Stat1-42 
/-
 counterparts, but STAT1Y701F
 46 
 is not sufficient to rescue the animals. Our studies are 43 
consistent with a potential contribution of Y701-unphosphorylated STAT1 to innate 44 
antibacterial immunity. 45 
 47 
Introduction 48 
 49 
The Jak-Stat signaling pathway regulates cellular responses to cytokines. The prototypic 50 
signal transducer and activator of transcription, STAT1, plays a crucial role in host defense by 51 
mediating the effects of interferons (IFN). In the canonical signaling pathway, all types of IFNs 52 
produce transcriptionally active STAT1 through Janus kinase (JAK)-mediated phosphorylation 53 
at Y701. The type II interferon (IFNγ) receptor complex phosphorylates STAT1 exclusively, thus 54 
producing homodimers of the transcription factor. These translocate to the cell nucleus and 55 
stimulate gene expression through binding to gamma interferon-activated sequences (GAS) 56 
within the IFN response regions of its target genes. By contrast, stimulation with type I or type III 57 
interferons (IFN-I and IFN-III, respectively) produces phosphorylated STAT1-STAT2 58 
heterodimers. These heterodimers associate with interferon regulatory factor 9 (IRF9) to form 59 
the IFN-stimulated gene factor 3 (ISGF3). After translocation to the nucleus, ISGF3 binds to 60 
interferon-stimulated response elements (ISRE) to stimulate gene expression [1, 2]. 61 
In addition to canonical, tyrosine-phosphorylated ISGF3 and STAT1 dimers, STATs 1 62 
and 2 form noncanonical complexes. Transcriptional responses by STAT1/IRF9 complexes in 63 
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complete absence of STAT2 or in absence of its phosphorylation, and by STAT2 complexes 64 
lacking STAT1 are documented in the literature [3-8]. Noncanonical complexes may contain 65 
transcriptionally active STATs without a phosphotyrosine (U-STATs) [8-10]. In Drosophila, U-66 
STATs associate with and maintain the stability of heterochromatin. Examples of this 67 
chromatin/STAT link exist also in Dictyostelium and C. elegans, organisms that appear to lack 68 
JAKs, but still have STATs [11-13]. Recent experimental evidence supports the concept that U-69 
STAT1 prolongs the expression of a subset of IFN-induced genes, many of which are involved 70 
in immune regulation [14]. It has been hypothesized that this occurs due to the accumulation of 71 
newly synthesized STAT1 through a positive feedback loop after interferon stimulation. 72 
Furthermore, it has been proposed that prolonged exposure of cells to IFNβ induces the 73 
expression of non-phosphorylated STAT2 (U-STAT2) and IRF9 which combine with U-STAT1 74 
and form the un-phosphorylated ISGF3 (U-ISGF3) [9]. U-ISGF3 in turn maintains the expression 75 
of a subset of the initially induced ISGs, leading to extended resistance to virus infection and 76 
DNA damage. 77 
In the present manuscript we investigate the role of U-STAT1 signaling in mice 78 
expressing a Stat1Y701F
 88 
 mutant. We report an important contribution of STAT1 tyrosine 79 
phosphorylation to a tonic signal increasing Stat1 expression. Extensive analysis of STAT 80 
activation and type I IFN-induced genes (ISGs) expression patterns demonstrate clear 81 
differences between macrophages lacking STAT1 and those expressing STAT1Y701F. These 82 
are reflected by an altered ability to limit the growth of the intracellular bacterial pathogen L. 83 
pneumophila. In spite of reduced STAT1Y701F protein amounts our work suggests a minor, but 84 
significant contribution of STAT1Y701F also to the innate response against another bacterial 85 
pathogen, L. monocytogenes. In summary our results provide evidence for biological activity of 86 
STAT1 in absence of its tyrosine phosphorylation. 87 
 89 
 90 
Results 91 
 92 
Jak-Stat signaling in Stat1Y701F
To investigate STAT1 activity in absence of its tyrosine phosphorylation we generated 94 
Stat1
 mice 93 
Y701F knock-in mice by targeting the gene with a construct encoding phenylalanine in 95 
position 701 (see materials and methods). We first examined heterozygous Stat1Y701F/+ mice. 96 
Importance of this genetic configuration stems from human patients, where Stat1Y701C 97 
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heterozygosity was classified as an autosomal dominant cause of Mendelian susceptibility to 98 
mycobacterial disease (MSMD) [15, 16]. We observed reduced Y701 phosphorylation of STAT1 99 
expressed from the WT allele in macrophages treated with either IFNβ or IFNγ (Fig. 1A). The 100 
kinetics of STAT1 phosphorylation were comparable to those of wild type cells (Fig. 1A). 101 
Reduced STAT1 phosphorylation on Y701 corresponded to decreased protein amounts.STAT2 102 
phosphorylation by IFNβ and total STAT2 amounts were normal. In line with diminished STAT1 103 
tyrosine phosphorylation, maximal expression of interferon-stimulated genes (ISGs) was lower 104 
after stimulation with either IFNβ (Fig. 1B) or IFNγ (Fig. 1C). The data suggest that Stat1Y701F 105 
When analyzing macrophages from mice carrying homozygous Stat1
heterozygosity causes reduced STAT1 expression and a correspondingly lower activation by 106 
the interferon receptors. 107 
Y701F
In accordance with expectations, the early transcriptional response to interferons after 4 121 
h was absent in Stat1
 mutation for 108 
STAT1 protein we noted strongly diminished amounts of total STAT1 (Fig. 2A, far right panel) 109 
and treatment with either IFNβ or IFNγ showed the expected loss of tyrosine phosphorylation 110 
(Fig. 2B and 2E). Strongly reduced amounts of STAT1 were also observed in livers, spleens 111 
and other organs of mutant animals (Fig. 2A). Reportedly, small amounts of IFN-I are secreted 112 
and accumulate in tissue milieu even in absence of infection. Constitutive IFN-I secretion was 113 
proposed to generate a tonic signal and cause a priming effect keeping cells in a state of 114 
alertness to other cytokines and contributing to immune homeostasis, maintenance of bone 115 
density, and antiviral and antitumor immunity [17]. Our data provide the first in vivo evidence 116 
that a tonic signal, most likely from the IFN-I receptor, increases Stat1 expression through a 117 
mechanism involving its phosphorylation on Y701. Intriguingly, the levels of constitutive STAT1 118 
phosphorylation are below the radar of the tools used for detection in most cell types, yet they 119 
are sufficient to exert a strong biological impact. 120 
-/- as well as Stat1Y701F cells (Fig. 2C and 2D). Previous studies in Stat1-/- 122 
cells demonstrated the occurrence of STAT1-independent, STAT2-dependent gene expression 123 
at a delayed stage of the transcriptional response to IFN-I [4, 6, 18-20]. Consistent with our 124 
previous report [3] stimulation with IFNβ caused STAT1-independent ISG expression starting 125 
around 8-12 h after treatment which required the presence of both STAT2 and IRF9 (Fig. 2D). 126 
Intriguingly, the presence of STAT1Y701F partially repressed STAT2/IRF9-dependent, STAT1-127 
independent genes at late stages of the IFNβ response. This relationship between genotype 128 
and expression profile was noted for many other investigated ISGs (Figure EV1B). The 129 
presence of STAT1Y701F inhibited the late expression of these genes through the 130 
STAT2/IRF9-dependent pathway. 131 
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After treatment with IFNγ, both Stat1Y701F and Stat1-/-
 138 
 macrophages failed to induce a 132 
transcriptional response of typical STAT1 target genes, such as Irf1, CIIta, Stat1 and Stat2 at 133 
any time after treatment (Fig. 2C and Figure EV1A). Consistent with their regulation by STAT1 134 
homodimers, lack of STAT2 or IRF9 had no or little impact on their expression (data not shown). 135 
These findings suggest that inhibition of late-stage gene expression by STAT1Y701F is 136 
selective for the response to IFN-I. 137 
Identical STAT2 tyrosine phosphorylation profile in Stat1-/- and Stat1Y701F
In order to further characterize the mechanism by which Stat1Y701F represses STAT1-140 
independent, STAT2/IRF9-dependent gene expression during the late IFN-I response, we 141 
considered a dominant-negative effect of the mutant at the level of JAK-mediated tyrosine 142 
phosphorylation. Therefore, tyrosine phosphorylation of STATs was profiled by western blot. In 143 
accordance with [3] STAT1 showed both delayed and prolonged phosphorylation in Stat2
 macrophages 139 
-/- and 144 
IRF9-/- macrophages stimulated with IFNβ compared to WT (Fig. 2E). 24 h of stimulation with 145 
IFNβ lead to upregulation of total STAT1 levels equally well in WT, Stat2-/- and IRF9-/-, while it 146 
remained absent in Stat1Y701F mutant macrophages (Fig. 2E and Figure EV1B). We also 147 
observed delayed, but prolonged phosphorylation of STAT2 in Stat1Y701F, Stat1-/- and IRF9-/- 148 
macrophages. Similar to STAT1, the total amounts of STAT2 were upregulated after 24 h of 149 
stimulation with IFNβ in all genotypes, but never as well as in WT, with Stat1Y701F
Apart from STAT1, STAT3 and STAT5 are known to contribute to tissue-specific 154 
interferon signaling [21]. To examine possible effects of STAT1Y701F on other STATs, we 155 
profiled the tyrosine phosphorylation of STAT3 and STAT5 by western blot. Compared to their 156 
WT counterparts, cells expressing STAT1Y701F displayed an unimpaired ability to 157 
phosphorylate STAT3 and STAT5 in response to IFNβ (Figure EV2). In accordance with this, 158 
amounts of STAT3 and STAT5 proteins were unchanged (Figure EV2). These data confirm the 159 
importance of STAT2 phosphorylation and signaling in STAT1-independent, STAT2/IRF9-160 
dependent gene expression, but did not explain the inhibition of the STAT2/IRF9 pathway by 161 
STAT1Y701F. 162 
 mutant having 150 
the weakest induction (Fig. 2E and Figure EV1B). The data suggest that the presence or 151 
absence of ISGF3 subunits exerts strong influence on both the tyrosine phosphorylation and 152 
upregulation of STATs 1 and 2. 153 
 163 
Cytoplasmic STAT1Y701F inhibits STAT1-independent STAT2 signaling 164 
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According to the Jak-Stat paradigm, STATs need to be phosphorylated on tyrosine to 165 
perform nuclear functions. This is also true for the U-Stat pathway proposed by Stark and 166 
coworkers because U-Stat function follows an early, tyrosine-dependent IFN response [14]. 167 
However, data with several STATs suggest a cytoplasmic or organelle-based function 168 
independently of tyrosine phosphorylation [22-28]. 169 
To examine the nuclear effect of STAT1Y701F, next-generation sequencing of 170 
chromatin-immunoprecipitations with antibodies to STAT1 (ChIP-Seq) was carried out. Both 171 
untreated and IFNβ stimulated macrophages of WT and Stat1Y701F
Consistent with the suppression of gene expression stimulated by STAT2/IRF9 176 
complexes, site-directed ChIP showed decreased STAT2 binding to both Mx2 and Irf7 ISRE 177 
sequences in Stat1
 genotypes were analyzed. 172 
The data provide no hint of nuclear presence of STAT1Y701F before or after IFNβ treatment. By 173 
contrast, binding of WT STAT1 was readily observed after IFNβ treatment (Figure EV3 shows 174 
Mx2, IRF7, Stat1 and Stat2 genes as representative examples).  175 
Y701F
In absence of evidence for nuclear STAT1Y701F activity, we performed 188 
immunofluorescence-based experiments to test whether the lack of individual ISGF3 subunits 189 
influences nuclear translocation of STAT2. Staining for STAT2 showed a comparable 190 
translocation of STAT2 to the nucleus 30 minutes after IFNβ stimulation of Stat1
 cells 24h after IFNβ treatment (Fig. 3A). In WT macrophages STAT1 178 
occupied the Mx2 ISRE site both 2 and 24 h after stimulation with IFNβ and binding required 179 
STAT2 (Fig. 3B) ChIP-reChIP experiments confirmed the simultaneous presence of STAT1 and 180 
STAT2 24 h after IFNβ stimulation on at least a subfraction of ISREs, suggesting that in WT 181 
cells late-stage induction involves both STAT1 and STAT2 (Fig. 3C). Further evidence for a 182 
suppression of STAT2/IRF9-mediated gene expression was obtained with the experiment 183 
shown in figure 3D. Transfection of STAT2 into STAT1-deficient fibroblasts stimulated late IFNβ-184 
induced gene expression. Expression of STAT1Y701F along with STAT2 suppressed gene 185 
expression when compared to the amount obtained with STAT2 overexpression alone. By 186 
contrast, WT STAT1 enhanced gene expression when transfected together with STAT2. 187 
-/- and IRF9-/- 191 
macrophages (Fig. 4A). 24 h after IFNβ stimulation, STAT2 was largely present in the nucleus 192 
of Stat1-/- and IRF9-/- macrophages. Importantly, the presence of STAT2 in the nucleus of 193 
Stat1Y701F macrophages was reduced in comparison to Stat1-/-
Together the data strongly suggests that STAT1Y701F leads to inhibition of STAT1-195 
independent, STAT2/IRF9-dependent late ISG expression through interaction with STAT2 in the 196 
cytoplasm, preventing it from nuclear translocation and DNA binding. 197 
 (Fig. 4B).  194 
 198 
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Stat1Y701F and Stat1-/-
 To examine whether suppression of late IFN-I signaling by STAT1Y701F alters cell-201 
autonomous antibacterial immunity provided by macrophages we infected the cells with two 202 
intracellular pathogens, L. pneumophila and L. monocytogenes. While IFN-I were shown to limit 203 
intracellular growth of L. pneumophila with a clear impact of the STAT1-independent delayed 204 
pathway [29-31], this activity of IFN-I is not seen upon infection with L. monocytogenes [32]. 205 
 macrophages and mice differ in their response to infection with 199 
Legionella pneumophila and Listeria monocytogenes 200 
Infection of untreated macrophages with L. pneumophila showed no difference between 206 
WT, Stat1-/-, or Stat1Y701F genotypes (Fig. 5A). As previously reported [3, 30],L. pneumophila 207 
growth was reduced after IFN-I treatment in both WT and Stat1-/- macrophages (Fig. 5B). 208 
Consistent with the suppressive activity of STAT1Y701F on the STAT1-independent pathway, 209 
Stat1Y701F macrophages showed less ability than Stat1-/-
During infection of WT macrophages with L. monocytogenes IFN-I is produced and 212 
causes STAT1 Y701 phosphorylation (figure 6A), but IFN-I does not affect growth in WT or 213 
Stat1-deficient macrophages [32]. We tested whether Stat1
 to inhibit L. pneumophila growth (Fig. 210 
5B). 211 
Y701F mutation and STAT1 deficiency 214 
have a different impact on the transcriptional response to L. monocytogenes by performing gene 215 
microarrays using cDNA from infected cells. Comparing StatY701F macrophages with WT, we 216 
found differentially expressed probes at an FDR of 0.1 at all observed time points during 217 
infection (Table 1, first row). In striking contrast to the comparison with the WT, no differentially 218 
regulated genes at an FDR of 0.1 were found at any time point when we compared Stat1Y701F 219 
and Stat1-/- (Table 1, second row). Among the genes higher expressed in WT versus Stat1-/- as 220 
well as Stat1Y701F macrophages was the Ifnβ gene (Fig. 6B). Thus, the strongly reduced 221 
production of type I IFN is likely to obscure potential effects IFN-I might exert on the innate 222 
response of Stat1Y701F
To investigate potential effects of unphosphorylated STAT1, we infected macrophages in vitro 225 
and determined intracellular L. monocytogenes growth. Strikingly, untreated macrophages with 226 
the STAT1
 cells and mice to L. monocytogenes. It may also preclude significant 223 
alterations of gene expression when compared to STAT1-deficiency. 224 
Y701F
STAT1 is essential for innate resistance of mice against L. monocytogenes infection [33, 229 
34]. Prompted by the result in isolated macrophages we determined the impact of STAT1Y701F 230 
in murine L. monocytogenes infection. Due to the strong decrease in STAT1 amounts caused 231 
 genotype inhibited L. monocytogenes replication better than BMDM with 227 
complete STAT1 deficiency (Fig. 7A), suggesting a role for U-Stat1. 228 Au
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by Y701F mutation with respect to WT, the most important read-out of these experiments is a 232 
potential gain of function in comparison to Stat1-/-
Stat1
 mice. 233 
Y701F mice infected with L. monocytogenes were highly susceptible to infection 234 
when compared to WT, but showed reduced bacterial loads in lungs, brain, liver and spleen 48 235 
h and 72 h after infection compared to the Stat1-/- mice (Fig. 7C). The difference between the 236 
Stat1-/- and Stat1Y701F genotypes was smaller at 72 h after infection and disappeared at the 237 
terminal stage of infection shortly before death (between 72 h and 144 h p.i.). Consistently, 238 
Stat1Y701F and Stat1-/- mice died at equal rates (Fig. 7B). We conclude that compared to STAT1 239 
deficiency the presence of STAT1Y701F delays L. monocytogenes replication, however, without 240 
the efficacy that would be needed for an increase in survival. The delay in bacterial spread and 241 
the concomitant generation of inflammatory infiltrates was further supported by 242 
immunohistochemistry. Stat1Y701F mice livers contained fewer L. monocytogenes (Fig. 8A) and 243 
immune cell infiltrates were smaller both in numbers and size compared to the Stat1-/- mice 244 
livers (Fig. 8A and 8B). As previously described [35], these infiltrates consisted mostly of 245 
neutrophils (Fig. 8A), while there were no clearly discernable differences in macrophage 246 
distribution in livers of all 3 genotypes (Figure EV4). Furthermore, measurements of alanine 247 
aminotransferase (ALT) levels in serum of infected mice showed a decrease of this liver 248 
damage parameter in Stat1Y701F mice compared to Stat1-/-
 252 
 (Fig. 8C). The data demonstrate a 249 
subtle, yet clearly discernible activity of U-STAT1 in the innate response against L. 250 
monocytogenes. 251 
Discussion 253 
STAT1 makes an essential contribution to innate immunity against viral and 254 
intramacrophagic bacterial disease. The objective of our study was to reveal any contribution of 255 
non tyrosine-phosphorylated STAT1 to innate immunity. Examining cells and organs of mice 256 
expressing a Stat1Y701F mutant the first observation of note was the strong dependence of 257 
STAT1 expression on its tyrosine phosphorylation through tonic signaling. None of the tested 258 
stimuli, including L. monocytogenes infection, caused upregulation of the Stat1 gene in absence 259 
of its tyrosine-phosphorylated product. Therefore, effects of the U-Stat pathway as defined by 260 
Stark and colleagues which rely on an increase in STAT abundance could not be examined. In 261 
addition, any results obtained for the immune response of Stat1Y701F cells or mice could not be 262 
compared to WT counterparts because a distinction between effects of tyrosine phosphorylation 263 
and effects of STAT1 abundance was not possible. To overcome this problem, we recorded 264 
gain or loss of function with respect to Stat1-/- cells and mice. With this approach we were able 265 
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to derive important insight into the cross-regulation of Stat1 and Stat2 genes and the 266 
mechanism of Stat signaling by the IFN receptors. We also demonstrated inhibition of delayed, 267 
STAT1-independent type IFN signaling by the STAT1Y701F mutant, owing to inhibited nuclear 268 
translocation of STAT2. Reduced inhibition of intracellular L. pneumophila growth in 269 
STAT1Y701F compared to Stat1-/-
Mice expressing one Stat1
 macrophages supports our interpretation of this activity. 270 
Other than L. pneumophila, STAT1-independent type I IFN signaling is thought to partially 271 
rescue cells and organisms from infection with viruses causing STAT1 inhibition or degradation. 272 
Finally we noted that the presence of STAT1Y701F inhibited L. monocytogenes replication, 273 
although not rescuing mice from lethal infection. 274 
Y701F allele in addition to a WT Stat1 allele showed reduced 275 
STAT1 expression, in accordance with phosphotyrosine-dependent autoregulation of the gene. 276 
Decreased tyrosine phosphorylation of WT STAT1 upon IFN treatment may thus reflect 277 
decreased protein amounts rather than a dominant-negative effect of STAT1Y701F. Several 278 
mutations of human Stat1 have been reported to impair the phosphorylation of STAT1 on Y701 279 
[36-38]. However, only one clinical case of two-generation kindred has been described to have 280 
a heterozygous Y701C Stat1 mutation [16]. In this report the patient’s blood leukocytes showed 281 
normal STAT1 levels, but reduction in STAT1 phosphorylation and binding to DNA after both 282 
type I and type II interferon treatment. Therefore Stat1Y701C mutation was concluded to be 283 
autosomal dominant. We cannot entirely rule out autosomal dominance of Stat1Y701F
In line with expectations, the early transcriptional response to both tested IFN types was 287 
completely lost in Stat1
 mutation in 284 
mice, but the reduced STAT1 expression appears to manifest a cell type or species-specific 285 
difference. 286 
Y701F mice. Tyrosine phosphorylation of STATs 2, 3 and 5 did not differ 288 
from that observed in Stat1-/- cells. This shows the lack of dominant-negative activity of the 289 
Y701F mutant with regard to STAT activation by the IFN receptor complex. STAT2 levels were 290 
slightly elevated in resting Stat1Y701F compared to Stat1-/- cells. However, upon IFNβ treatment 291 
STAT2 protein increased to higher levels in Stat1-/- cells, but much less so in Stat1Y701F cells or 292 
IRF9-/- cells. In agreement with data in Figure EV1, this shows that the Stat2 gene is a target of 293 
STAT1-independent STAT2/IRF9 signaling which, like many other genes examined in our study, 294 
is partially suppressed by STAT1Y701F. Regarding the mechanism of STAT1Y701F-mediated 295 
ISG suppression, our ChIP-Seq data support the conclusion that it is not through activity in the 296 
cell nucleus. While we cannot exclude insufficient sensitivity of this technology to detect very 297 
small STAT1Y701F amounts, a clear effect on STAT2 nuclear translocation suggests a 298 
cytoplasm-based mode of action. The finding that the small amounts of STAT1Y701F produce 299 
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this significant effect is explained on the one hand by reduced nuclear presence of 300 
hemiphosphorylated STAT1Y701F/STAT2 dimers and by the resulting defect in STAT2 301 
upregulation. Stat1Y701F/STAT2 dimers might either have reduced ability to enter the nucleus 302 
or to persist in this cell compartment through stable association with chromatin [39, 40]. This 303 
would be expected to reduce the amount of gene-associated STAT2/IRF9 complexes, an 304 
interpretation compatible both with the analysis of STAT2 subcellular distribution (Fig. 4A) and 305 
the site-directed ChIP demonstrating reduced STAT2 binding to ISRE-containing ISG promoters 306 
in Stat1Y701F
Unlike Stat2, the Stat1 gene increased profoundly after IFNβ treatment not only in WT, 308 
but also in all investigated genotypes except Stat1
 cells (Fig. 3A). 307 
Y701F. This result further emphasizes the 309 
importance of Y701 phosphorylation for Stat1 gene expression. Enhanced expression in Stat2-/- 310 
and Irf9-/- cells shows that IFNβ regulation of the Stat1 gene does not involve the ISGF3 311 
complex. Surprisingly and in contrast, STAT1 maintenance in resting cells appears to require 312 
ISGF3 as a profound drop occurs in Stat2-/- as well as IRF9-/-
Innate immunity to L. monocytogenes was strongly reduced in Stat1
 macrophages. 313 
-/- as well as 314 
Stat1Y701F mice, in accordance with its dependence on IFNγ and the lack of any apparent 315 
transcriptional activity of STAT1Y701F on IFNγ-inducible genes (Fig. 7A and Figure EV3) [41, 316 
42]. In fact, STAT1Y701F was not able to rescue from lethal infection irrespective of the 317 
inoculum size (Fig. 7B). In spite of this, replication of the bacteria in infected Stat1Y701F cells and 318 
organs was delayed, as were the examined hallmarks of liver inflammation and damage. At 319 
present we cannot pinpoint the mechanism behind this. Speculatively the altered response to 320 
IFN-I might be a contributing factor. Although Listeria-infected Stat1-/- and Stat1Y701F cells 321 
produce less IFN-I (Fig. 6B) levels of cytokine are expected to stimulate cells, albeit to a lesser 322 
degree. In absence of IFN-I signaling, Listeria-infected mice show decreased bacterial burden 323 
and increased survival. This correlates with reduced apoptosis of splenic lymphocytes [43-46]. 324 
The impact of the late phase of the IFN-I response during which ISG transcription can occur 325 
without STAT1 and during which STAT1Y701F exerts its inhibitory activity on immunity to L. 326 
monocytogenes is unclear. However, the biological relevance of the STAT1-independent 327 
pathway is documented by antiviral activity of Stat1-/- cells against viruses (Dengue virus - [19]; 328 
MV - [18]), by type I IFN-mediated viral pathology in mice [47] and antibacterial macrophage 329 
activity against L.pneumophila (Fig. 5) [3, 30]. Based on our findings and these reports in the 330 
literature we hypothesize that late-phase suppression of the IFN-I response reduces its known 331 
detrimental effects on innate resistance to L. monocytogenes. However, reduced L. 332 
monocytogenes growth in Stat1Y701F macrophages compared to Stat1-/- suggests an additional, 333 
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cell-autonomous effect of U-STAT1 because cells lacking the type I IFN receptor do not 334 
reproduce this phenotype [32] and there is no IFNγ in the experimental system. Extensive 335 
microarray analyses are inconsistent with a nuclear activity of the mutant in infected cells, 336 
suggesting a hitherto undefined cytoplasmic route through which U-STAT1 influences 337 
antibacterial resistance. 338 
In this regard, our observation that L. monocytogenes infection causes phosphorylation 339 
of the STAT1Y701F mutant at S727 (data not shown) may be of importance, as several reports 340 
suggest that at least some biological activities of U-STATs require phosphorylation at this 341 
residue. Whereas nuclear S727 phosphorylation by CDK8 enhances transcriptional activity of 342 
the tyrosine-phosphorylated STAT1 dimer [48], cytoplasmic S727 phosphorylation of U-STAT1 343 
was linked to diverse biological processes such as the apoptotic response to TNF or the 344 
regulation of NK cytotoxicity [49, 50]. Therefore, it is tempting to speculate that the cytoplasmic 345 
kinase causing S727 phosphorylation of U-STAT1 in L. monocytogenes-infected macrophages 346 
is part of a STAT1-dependent antibacterial pathway. 347 
In conclusion our analysis of Stat1Y701F
Materials and methods 364 
 cells and mice supports the idea of U-Stat activity 348 
and yielded interesting insight into the cross-regulation of STATs. How relevant is this 349 
experimental system for Stat signaling in WT cells? Generally speaking, the gain of innate 350 
immunity versus STAT1 deficiency seen in our studies is small and hard to extrapolate to a 351 
contribution of unphosphorylated STAT1 in WT animals. The best our experimental model can 352 
achieve is to reveal a potential of unphosphorylated STAT1, but it cannot provide final proof that 353 
this potential is realized in WT cells or animals. The ChIP analysis of figure 3C demonstrates 354 
WT STAT1 at ISREs both early and late after IFNβ treatment and that it co-occupies the same 355 
sites with STAT2. This suggests that a STAT1-independent pathway employing STAT2/IRF9 is 356 
less prominent in WT cells. Therefore, a selective inhibition of this pathway by 357 
unphosphorylated STAT1, can neither be ruled out nor confirmed. From a broader perspective 358 
the finding demonstrating STAT1Y701F mutant inhibition of STAT2 translocation to the nucleus 359 
suggests that the subcellular distribution of STAT2 in type I IFN-treated WT cells may be 360 
regulated by the relative amount of U-STAT1. Moreover, the scenario studied here applies to 361 
patients with Stat1 mutations that inhibit tyrosine phosphorylation [15, 16] or to cells in which 362 
pathogens disrupt Jak-Stat signal transduction. 363 
 365 
Mice. Mice containing an A->T point mutation in exon 23 of the Stat1 gene, causing a 366 
change of Y701 to F were generated following the strategy described for Stat1S727A mice by [51]. 367 
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In brief, a targeting construct spanning intron 22 through exon 23 was made, inserting a floxed 368 
Neo cassette in intron 22 and a DT gene after exon 23 for selection of homologous 369 
recombinants. The construct was introduced in ES cells and homologous recombinants 370 
identified by Southern blot of Bgl II-restricted genomic DNA. The point mutation was verified by 371 
PCR amplification of the tyrosine-containing exon 23 and digestion with restriction enzyme Hinf. 372 
The A->T transversion generates an additional Hinf site that divides the PCR amplicon into 373 
fragments of 355 bp and 175 bp length. A positive ES clone (A10) was identified and the neo 374 
cassette excised after infection with a Cre-expressing Adenovirus. Neo-deleted ES cells were 375 
used for blastocyst injection and the generation of chimeric mice. Mice transmitting the mutant 376 
allele to their progeny were backcrossed to C57BL/6N mice. A pure C57BL/6N congenic strain 377 
was established by marker-assisted selection. C57BL/6N and congenic Stat1-/-, Stat2-/- and 378 
IRF9-/-
All of the animal experiments have been approved by the Vienna University of Veterinary 380 
Medicine institutional ethics committee and performed according to protocols approved by the 381 
Austrian law (BMWF 68.205/0032-WF/II/3b/2014). General condition and behavior of the 382 
animals during the experiments was controlled by FELASA B degree holding personnel. The 383 
progress of the disease was monitored every 2 to 4 hours during the “day phase” (7 a.m. to 7 384 
p.m.) or both during the “day” and the “night phase” depending on the condition of the animals. 385 
In survival or terminal stage experiments, humane endpoint by cervical dislocation was 386 
conducted if death of the animals was expected within next few hours. Animal husbandry and 387 
experimentation was performed under the Austrian national law and the ethics committees of 388 
the University of Veterinary Medicine Vienna and according to the guidelines of FELASA which 389 
match those of ARRIVE. 390 
 mice were housed under SPF conditions [52-54].  379 
 391 
Infection of mice and in vivo colony forming units (CFU) assays. Mice were infected 392 
by intraperitoneal injection with the indicated inoculum sizes of the LO28 strain of L. 393 
monocytogenes. The bacteria were prepared as previously described [55]. For infection, 394 
bacteria were washed, diluted in respective concentration in PBS (Sigma) and injected into 8- to 395 
10-week old, gender matched C57BL/6N (WT), Stat1Y701F and Stat1-/- mice. The infectious dose 396 
was controlled by plating serial dilutions on Oxford agar (Merck Biosciences) or brain heart 397 
infusion (BHI; BD Biosciences) agar plates. For the survival assays, mice were monitored over 398 
the course of 10 days. For detection of bacterial loads in liver, spleen, brain and lungs (CFU 399 
assays), mice were sacrificed at the indicated time points, organs were harvested and 400 
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homogenized in PBS. The 1:10 serial dilutions were plated on Oxford agar plates (lungs) or BHI 401 
agar plates. The colonies were counted after a 24 h incubation at 37 °C. 402 
 403 
Histology. Mouse organs were harvested, fixed in 4 % paraformaldehyde overnight and 404 
dehydrated in 70 % ethanol overnight. Samples were further embedded in paraffin and cut on a 405 
microtome into 3 μm sections. Immunohistochemical detection of L. monocytogenes and of 406 
Ly6C/Ly6G+
 421 
 cells in infected liver tissue was performed as previously described [35]. In brief, 407 
sections for the identification of L. monocytogeneswere incubated in 50 % methanol and 3 % 408 
hydrogen peroxide to inhibit endogenous peroxidase activity and then incubated with pronase 409 
(Roche); washed in PBS containing 0.05 % Tween (PBS-T) and blocked in 5 % normal goat 410 
serum. Sections were reacted with primary antibody against L. monocytogenes (Abcam) and 411 
binding was detected using HRP rabbit/mouse polymer (Dako) and AEC+ high chromogen 412 
substrate. The counter stain was done with hematoxylin. For Ly6C/Ly6G (Gr-1) 413 
immunohistochemistry liver sections were incubated in 50 % methanol and 3 % hydrogen 414 
peroxide to inhibit endogenous peroxidase activity and then boiled in 10 mM sodium citrate 415 
antigen unmasking solution. The samples were blocked in 3 % normal goat serum and stained 416 
overnight with primary Ly6C/Ly6G antibody (BD Pharmingen). On the next day samples were 417 
incubated with biotinylated rabbit anti-rat IgG (Vector Laboratories), washed and incubated with 418 
ABC reagent (Vector Laboratories). Binding was visualized using AEC+ high sensitivity 419 
chromogen substrate (Dako). Samples were counterstained with hematoxylin. 420 
Analysis of alanine aminotransferase levels (ALT). Mice were infected with 1x105
 425 
 422 
LO28 L. monocytogenes intraperitoneally and sacrificed 72 h after infection. ALT levels were 423 
measured in mice serum using a Roche COBASc11 analyzer (Labor Invitro, Vienna, Austria). 424 
Cell culture. Bone marrow derived macrophages (BMDMs) were differentiated from 426 
bone marrow isolated from femurs and tibias of 6-8 week old mice. Cells were cultured in 427 
DMEM (Sigma-Aldrich) supplemented with 10 % of FCS (Sigma-Aldrich), 10 % of L929-cell 428 
derived CSF-1 and 100 units/ml penicillin, 100 µg/ml streptomycin (Sigma-Aldrich) as previously 429 
described [55]. The culture contained >99 % of F4/80+ cells. 430 
 431 
In vitro colony forming units (CFU) assay.  432 
L. monocytogenes: For in vitro colony forming assays (CFUs), cells were infected with L. 433 
monocytogenes LO28 at a multiplicity of infection (MOI) of 10 in antibiotic-free medium. After 1 434 
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h the medium was replaced with medium containing 50 μg/mL of gentamicin in order to 435 
eliminate all external bacteria. After one more hour the medium was exchanged again with 436 
medium containing 10 μg/mL gentamicin. At indicated time points, cells were lysed in sterile 437 
water and CFUs were determined by plating 1:10 serial dilutions on BHI (BD Biosciences) agar 438 
plates. Colonies were counted after 24 h incubation at 37 °C. 439 
L.pneumophila: The L. pneumophila JR32 Fla- (flagellin deficient) strain was grown in 440 
AYE (ACES-buffered yeast extract) 
 445 
broth or on CYE (charcoal yeast extracts) plates as 441 
previously described [30]. BMDMs were infected at MOI 0.25 and cells were lysed in sterile 442 
water at indicated time points. Numbers of CFUs were determined by plating 1:10 serial 443 
dilutions plated on CYE plates. Colonies were counted after 72 h of incubation at 37 °C.  444 
Preparation of whole cell lysates and western blot analysis. 3×106 BMDMs were 446 
infected with L. monocytogenes at MOI 10 as described above, or treated with 250 IU/mL of 447 
IFNβ (PBL interferon source) or 5 ng/mL of IFNγ (Affymetrix - eBioscience). For whole cell 448 
lysates, BMDMs were lysed in 80 μL of Frackelton buffer (10 mM Tris, 30 mM Na4P2O7, 50 mM 449 
NaCl, 50 mM NaF, 1% triton X-100, 0.1 mM PMSF, 1 mM DTT, 0.1 mM Na3VO4, pH=7.5) 450 
supplemented with complete protease inhibitors diluted 1:100 (Roche). Proteins were separated 451 
on 10 % SDS-polyacrylamide gels and blotted onto cellulose membranes (Optitran BA-S 83, GE 452 
Healthcare Life Sciences) using a standard semi-dry protocol (1.5 h, 32 mA per gel). For tissue 453 
western blots, spleens were lysed in 1 mL Frackelton buffer and livers were lysed in 5 volumes 454 
of buffer (50 mM TrisHCl pH=8, 150 mM NaCl, 1% TX-100, 0.1% SDS, 5 mM EDTA, 1 mM 455 
EGDA, inhibitors). The following primary antibodies were used: STAT1 C-terminal [56], STAT1 456 
(clone E-23, Santa Cruz), phospho-Y701 STAT1 (Cell Signaling), phospho-Y689 STAT2 457 
(Millipore), STAT2 (Millipore), STAT3 (Cell Signaling), phospho-Y705 STAT3 (Cell Signaling), 458 
phospho-Y694 STAT5 (BD Biosciences), STAT5 (Millipore) and tubulin (Sigma). Secondary 459 
antibodies were purchased from Li-COR and blots were detected on Odyssey CLx®
 462 
 Infrared 460 
Imaging System (Li-COR). 461 
RNA isolation, cDNA synthesis and Q-PCR. 1x106 BMDMs were infected with L. 463 
monocytogenes at MOI 10 as described above, or treated with 250 IU/mL of IFNβ (PBL 464 
interferon source) or 5 ng/mL of IFNγ (Affymetrix - eBioscience). At indicated time points cells 465 
were lysed in RA1 buffer from the NucleoSpin II RNA isolation kit (Macherey-Nagel). Total RNA 466 
isolation was further performed according to the manufacturer's instructions. cDNA was 467 
synthesized using 200ng of isolated RNA. Q-PCR was performed using GoTaq® qPCR Master 468 
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Mix (Promega) according to the manufacturer's instructions. Samples were amplified on a 469 
Mastercycler realplex real-time PCR system (Eppendorf). mRNA levels were calculated and 470 
normalized to GAPDH using the ΔCT
 474 
 method. Relative fold-induction was calculated by 471 
normalizing all genotypes and treatments to untreated WT. Sequences of primers are listed in 472 
Appendix table 1. 473 
Cell transfection. Stat1-/-
 479 
 fibroblasts were grown to 70% confluency in 6 cm dishes. The 475 
cells were transfected with 1 µg of each expression plasmid using 8 µl of Turbofect™ reagent 476 
(Thermo Scientific). 24h later the cells were treated with IFNß for 48h, followed by extraction of 477 
RNA as described above.    478 
Immunofluorescence. 2x105
 490 
 BMDMs were seeded on glass cover slides, treated with 480 
250 IU/mL IFNβ and fixed with 3 % paraformaldehyde for 20 minutes at room temperature. Cells 481 
were permeabilized with 0.1 % saponin in 0.5 M NaCl PBS. Blocking and incubation with STAT2 482 
primary antibody [3] and secondary anti-rabbit Alexa Fluor® 488 (Life Technologies) were done 483 
in 0.1 % saponin and 1 % BSA in 0.5 M NaCl PBS. Samples were mounted in DAPI-containing 484 
mounting media Dapi-Floromount-G (SouthernBiotech). Confocal images were acquired using a 485 
Zeiss LSM 710 microscope with 63X (NA 1.4) oil objectives. Images were processed and 486 
analyzed using the ImageJ software and relative fluorescence was calculated according to the 487 
corrected total cell fluorescence (CTCF) formula (CTCF= Integrated density-(area of selected 488 
cell x mean fluorescence background readings)) as previously described [57, 58]. 489 
ChIP-seq, ChIP and ChIP-re-ChIP. Chromatin immunoprecipitation (ChIP) using 491 
DynaBeads Protein G (Invitrogen) was performed as described [59]. BMDMs were treated with 492 
250 IU/mL of IFNβ. ChIP was performed using STAT1 (clone E-23, Santa Cruz) or STAT2 493 
antibody (clone C-20, Santa Cruz). Levels of precipitated chromatin were measured by Q-PCR 494 
as described above. Primers used for Q-PCR are listed in appendix table 1. Data were 495 
normalized to input and to the sample from untreated wild type cells. For ChIP-seq precipitated 496 
chromatin was sonicated into 200 to 300 bp long fragments. 5-10 ng of DNA precipitated by 497 
ChIP was used as the starting material for the generation of sequencing libraries using the 498 
KAPA library preparation kit for Illumina systems. Completed libraries were quantified with a 499 
BioanalyzerdsDNA 1000 assay kit (Agilent) and a Q-PCR NGS library quantification kit (KAPA). 500 
Cluster generation and paired-end sequencing was achieved with a HiSeq 2000 system with a 501 
read length of 100 bp according to the manufacturer's guidelines (Illumina). Samples were 502 
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multiplexed using unique adaptors; all the untreated samples were run on the first lane and the 503 
treated ones on the second lane of the flow cell. ChIP-re-ChIP experiments were preformed as 504 
previously described [60] using STAT1 (clone E-23, Santa Cruz) or STAT2 antibody (clone C-505 
20, Santa Cruz). In short, the immune complexes were eluted with 10 mM DTT for 40 min at 506 
room temperature with agitation after which they were diluted 40-fold in ChIP dilution buffer and 507 
re-immunoprecipitated. 508 
 509 
ChIP-Seq analysis: Quality based trimming was performed at the 3’ end of raw reads 510 
using the “trim-fastq.pl” script of the PoPoolation toolbox [61], where all trimmed reads with 511 
length less than 30 bp were discarded. Quality controlled reads were mapped to the mouse 512 
genome (UCSC, mm10) using Bowtie [62] where all non-unique alignments were discarded. 513 
Post-alignment filtering: reads mapped in a proper pair were selected and PCR duplicates were 514 
removed using SAMtools [63]. Peak-calling was performed using MACS [64] with default 515 
parameters. Significant peaks were annotated to the nearest genes using PeakAnalyzer [65]. 516 
ChIP-Seq data are deposited at ArrayExpress under accession number E-MTAB-3597 517 
(https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3597/). 518 
  519 
Microarray. Total RNA from mouse bone marrow-derived macrophages (BMDM) 520 
treated with L. monocytogenes for 6, 12 or 24 hours was purified using Trizol (Invitrogen, USA) 521 
and RNeasy Mini Kit (Qiagen, Germany). The RNA samples were collected from 3 sets of 522 
independent experiments. Samples were prepared by the Genomics Core of Lerner Research 523 
Institute, Cleveland Clinic, using 1 g of total RNA and Illumina Mouse Ref-8 v2 Expression Bead 524 
Chips (Illumina Inc. USA). After filtering to remove probes expressed at or below background 525 
levels in the WT, 7644 probes remained. The log expression level of each remaining probe was 526 
analyzed with a linear model with genotype, timepoint, and replicate as factors. The mean 527 
expression of the Stat1Y701F genotype was contrasted with that of the WT and Stat1-/-. 528 
Subsequently a Benjamini-Hochberg false discovery rate analysis was performed independently 529 
for the three comparisons among genotypes. Microarray data are deposited at ArrayExpress 530 
under accession number E-MTAB-3598 (https://www.ebi.ac.uk/arrayexpress/experiments/E-531 
MTAB-3598/
 533 
). 532 
Statistical analysis. Bacterial loads of organs and ALT levels in serum were compared 534 
using the Mann-Whitney test and middle values represent medians. Bacterial loads in in vitro 535 
CFU assays were compared with the Student’s t-test and bars on the graph represent the mean 536 
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values with error bars that represent standard deviation (SD). mRNA expression data also 537 
represent the mean values with standard error of mean (SEM). The differences in mRNA 538 
expression data were compared using the ratio t-test. All statistical analyses were performed 539 
using the GraphPad Prism (Graphpad) software. Asterisks denote statistical significance as 540 
follows: ns, p>0.05; *, p≤ 0.05; **, p≤ 0.01; ***, p≤ 0.001. 541 
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 741 
 742 
Figure Legends 743 
 744 
Figure 1 - Interferon signaling in mice bearing heterozygous Stat1Y701F mutation 745 
resembles that of human cells with heterozygous Stat1Y701C
A Western blot analysis STAT expression and phosphorylation. Bone marrow derived 747 
macrophages (BMDMs) of wild type (WT), Stat1
 mutation. 746 
Y701F/+ (WT/YF) or Stat1-/-
B Effect of STAT1
 (S1) mice were treated 748 
with 250 IU/mL of IFNβ or 5 ng/mL of IFNγ for 0.5, 6, 12 and 24 h. Whole cell extracts were 749 
collected and tested in western blot for levels of phosphorylation of STAT1 (Y701) and STAT2 750 
(Y689) and total level of STAT1 and STAT2. The blots are representative of more than 3 751 
independent experiments. 752 
Y701Fheterozygosity on the expression of type I IFN-induced genes 753 
(ISG). BMDMs of wild type (WT), Stat1Y701F/+ (WT/YF) or Stat1-/-
C Effect of STAT1
 (S1) mice were treated with 250 754 
IU/mL of IFNβ for 4 and 48 h. Gene expression was measured by Q-PCR and normalized to 755 
Gapdh and to the expression levels in untreated wild type cells. The bars represent mean 756 
values with the standard deviations (SD) of three independent experiments.  757 
Y701Fheterozygosity on the expression of IFNγ-induced genes. BMDMs 758 
of wild type (WT), Stat1Y701F/+ (WT/YF) or Stat1-/-
 763 
 (S1) mice were treated with 5 ng/mL of IFNγ for 759 
4 and 48 h. Gene expression was measured by Q-PCR and normalized to Gapdh and to the 760 
expression levels in untreated wild type cells. The bars represent mean values with the standard 761 
deviations (SD) of three independent experiments.  762 
Figure 2 - STAT1 expression and interferon signaling in Stat1Y701F
A Effect of STAT1
 mice. 764 
Y701F homozygosity on STAT1 expression in mouse cells and organs. 765 
Spleens, livers or bone marrow derived macrophages (BMDMs) were isolated from wild type 766 
(WT), Stat1Y701F (YF) and Stat1-/- (S1) mice. Whole cell extracts were collected and tested for 767 
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levels of total Stat1 in western blot. The blots are representative of more than 3 independent 768 
experiments. 769 
B Effect of STAT1Y701F homozygosity on STAT1 phosphorylation at Y701. BMDMs were 770 
isolated from wild type (WT), Stat1Y701F (YF) and Stat1-/-
C Effect of STAT1
 (S1) mice and stimulated for 30 min 771 
with 250 IU/mL of IFNβ or 5 ng/mL of IFNγ. Whole cell extracts were collected and tested for 772 
levels of STAT1 phosphorylation on Y701 in western blot. The blots are representative of more 773 
than 3 independent experiments. 774 
Y701Fhomozygosity on the expression of IFNγ-induced genes. BMDMs 775 
of wild type (WT), Stat1Y701F (YF) and Stat1-/-
D Effect of STAT1
 (S1) mice were treated with 5 ng/mL of IFNγ for 4 776 
or 48 h. Gene expression was measured by Q-PCR and normalized to Gapdh and to the 777 
expression levels in untreated wild type cells. Bars represent a mean value of 3 independent 778 
experiments. Error bars represent standard error of the mean (SEM); asterisks denote the level 779 
of statistical significance (ns, p>0.05); the p-values were calculated using paired ratio t-test. 780 
Y701Fhomozygosity on the expression of type I IFN-induced genes 781 
(ISG). BMDMs were isolated from wild type (WT), Stat1Y701F, Stat1-/-, Stat2-/- and IRF9-/-
E STAT1 and STAT2 phosphorylation in Stat1-/-, Stat1
 mice 782 
treated with 250 IU/mL of IFNβ for 4, 8, 12, 24 or 48 h. Gene expression was measured by Q-783 
PCR and normalized to Gapdh and to the expression levels in untreated wild type cells. Bars 784 
represent a mean value of 3 independent experiments. Error bars represent standard error of 785 
the mean (SEM); asterisks denote the level of statistical significance (ns, p>0.05; *, p≤ 0.05; **, 786 
p≤ 0.01); the p-values were calculated using paired ratio t-test. 787 
Y701F, Stat2-/- and Irf9-/- 788 
macrophages. BMDMs were isolated from wild type (WT), Stat1Y701F (YF), Stat1-/- (S1), Stat2-/- 789 
(S2) and IRF9-/-
 794 
 (IRF9) mice and treated with 250 IU/mL of IFNβ for 30 min or 6, 12 or 24 h. The 790 
whole cell extracts were collected and tested in western blot for levels of phosphorylation of 791 
STAT1 on Y701 and of STAT2 on Y689. The same cell extracts were tested for total levels of 792 
STAT1 and STAT2. The blots are representative of more than 3 independent experiments. 793 
Figure 3 - Presence of the STAT1Y701F mutant reduces IFNβ-stimulated binding of 795 
STAT2 to nuclear ISRE sequences. 796 
A IFNβ-stimulated binding of STAT2 to ISRE sequences of Mx2 and IRF7 promoters. 797 
Bone marrow derived macrophages (BMDMs) of wild type (WT), Stat1Y701F (YF), Stat1-/- (S1), 798 
Stat2-/- (S2) and IRF9-/- (IRF9) mice were treated with 250 IU/mL of IFNβ for 2 or 24 h. Cells 799 
were crosslinked, sonicated and immunoprecipitated with STAT2-specific antibody. The amount 800 
of precipitated DNA was measured by Q-PCR. Bars represent a mean value of 3 independent 801 
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experiments. Error bars represent standard error of the mean (SEM); asterisks denote the level 802 
of statistical significance (**, p≤ 0.01); the p-values were calculated using paired ratio t-test. 803 
B Impact of STAT2 deficiency on IFNβ-stimulated STAT1 association with the Mx2 804 
ISRE. BMDMs of wild type (WT), Stat1-/- (S1) and Stat2-/-
C Simultaneous association of STAT1 and STAT2 with the Mx2 ISRE analyzed by ChIP-810 
reChIP. BMDMs of wild type (WT) mice were treated with 250 IU/mL of IFNβ for 2 or 24 h. Cells 811 
were crosslinked, sonicated and immunoprecipitated with either STAT1-specific antibody and 812 
re-immunoprecipitated with STAT2-specific antibody or vice versa. The amount of precipitated 813 
DNA was measured by Q-PCR. Bars represent mean values of three independent experiments; 814 
error bars represent standard deviation (SD). 815 
 (S2) mice were treated with 250 IU/mL 805 
of IFNβ for 2 or 24 h. Cells were crosslinked, sonicated and immunoprecipitated with STAT1-806 
specific antibody. The amount of precipitated DNA was measured by Q-PCR. Bars represent 807 
mean values of three independent experiments; error bars represent standard error of mean 808 
(SEM). 809 
D Impact of STAT1Y701F on delayed, STAT2-mediated expression of IFN-induced 816 
genes. Stat1-/-
 823 
 fibroblasts were transfected with plasmids driving expression of the indicated 817 
proteins. 24 h after transfection, 250 IU/ml of IFNβ was added to the transfected cells and ISG 818 
expression was determined by Q-PCR after 48h of cytokine treatment. Gene expression was 819 
measured by Q-PCR and normalized to Gapdh. Bars represent a mean value of 3 independent 820 
experiments. Error bars represent standard error of the mean (SEM) and asterisks denote the 821 
level of statistical significance (*, p≤ 0.05); the p-values were calculated using paired ratio t-test. 822 
Figure 4 - STAT1Y701F mutant reduces IFNβ-stimulated nuclear translocation of STAT2. 824 
A Analysis of STAT2 nuclear translocation by immunofluorescence. Bone marrow 825 
derived macrophages (BMDMs) of wild type (WT), Stat1Y701F (YF), Stat1-/- (S1), Stat2-/- (S2) and 826 
IRF9-/-
B Quantitative evaluation of STAT2 nuclear translocation. The intensity of STAT2-832 
dependent immunofluorescence over DNA staining (DAPI) was quantified using ImageJ 833 
software in 20 cells from two independent experiments. Bars represent a mean with standard 834 
 (IRF9) mice were seeded on cover slips and stimulated with 250 IU/mL of IFNβ for 30 827 
min or 24 h. The cells were fixed and stained for STAT2 specific antibody followed by 828 
Alexafluor® 488 conjugated secondary antibody (green). Nuclei were stained with DAPI (blue). 829 
Studies are representative of more than three independent experiments. The scale bars 830 
represent 10 µm. 831 Au
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deviation (SD) and asterisks denote the level of statistical significance (***, p≤ 0.001); p-value 835 
was calculated using unpaired t-test. 836 
 837 
Figure 5 - STAT1Y701F mutant counteracts the inhibition of L. pneumophillareplication 838 
by delayed, STAT2/IRF9-dependent IFN signaling. 839 
A Legionella pneumophila growth in unstimulated macrophages. Bone marrow derived 840 
macrophages (BMDMs) of wild type (WT), Stat1Y701F, Stat1-/-
B Legionella pneumophila growth in IFNβ-treated macrophages. Bone marrow derived 845 
macrophages (BMDMs) of wild type (WT), Stat1
 mice were seeded on in the 24-841 
well plates and infected with L. pneumophila (JR32 Fla-, MOI 0.25). The numbers of colony 842 
forming units (CFUs) were determined 24 h, 48 h and 72 h after infection on charcoal yeast 843 
extract plates (CYE). The 0 time point was collected 1.5 h after the infection. 844 
Y701F, Stat1-/-
The studies in A and B represent six biological repeats and the data are represented as mean 851 
values. Asterisks denote statistically significant differences between CFU numbers from 852 
Stat1
 mice were seeded in 24-well 846 
plates, treated with 500 U/mL of IFNβ and then infected with L. pneumophila (JR32 Fla-, MOI 847 
0.25). The numbers of colony forming units (CFUs) were determined 24 h, 48 h and 72 h after 848 
infection on charcoal yeast extract plates (CYE). The 0 time point was collected 1.5 h after the 849 
infection. 850 
Y701F and Stat1-/-
 854 
 cells (***, p≤ 0.001); p-values were calculated using unpaired t-test. 853 
Figure 6 - Interferon signaling in L. monocytogenes infected Stat1Y701F
A Western blot analysis of STAT1 tyrosine phosphorylation. Bone marrow derived 857 
macrophages (BMDMs) of wild type (WT), Stat1
 bone marrow 855 
derived macrophages. 856 
Y701F (YF) and Stat1-/-
B Impact of Stat1Y701F mutation, or of deletion of ISGF3 subunits on the expression of 862 
the IFNβ gene. BMDMs of wild type (WT), Stat1
 (S1) mice were infected 858 
with L. monocytogenes (LO28, MOI 10) for 5 or 6 h. Whole cell extracts were collected and 859 
tested in western blot for levels of total STAT1 and phosphorylation of STAT1 on tyrosine 860 
(Y701). The blots are representative of more than 3 independent experiments. 861 
Y701F, Stat1-/-, Stat2-/- and IRF9-/-
 867 
 mice were 863 
infected with L. monocytogenes (LO28, MOI 10) for 4, 8, 12, 24 or 48 h. Levels of Ifnβ gene 864 
expression were determined by Q-PCR. Bars represent mean values of three independent 865 
experiments. Error bars represent standard error of mean (SEM). 866 
Figure 7 - STAT1Y701F contributes to clearance of L. monocytogenes infection.  868 
Au
th
or
 M
an
us
cr
ip
t
This article is protected by copyright. All rights reserved 
A Impact of Stat1 deficiency or of STAT1Y701F mutation on the growth of Listeria 869 
monocytogenes in macrophages. Bone marrow derived macrophages (BMDMs) of wild type 870 
(WT), Stat1Y701F and Stat1-/-
B Survival of mice infected with L. monocytogenes. 10 wild type (WT), Stat1
 mice were infected with L. monocytogenes (LO28, MOI 10). Colony 871 
forming unit (CFU) numbers were determined 1, 2, 4, 6 or 8 h after infection by plating on brain-872 
heart-infusion (BHI) agar plates. The graph represents biological triplicates and the data are 873 
represented as mean values. Error bars represent standard deviation (SD) and asterisks denote 874 
statistically significant differences (ns, p>0.05; **, p≤0.01; ***, p≤ 0.001); p-values were 875 
calculated using unpaired t-test. 876 
Y701F and 877 
Stat1-/- mice per group were infected by intraperitoneal injection of 1x 102
C Organ pathogen burdens of mice infected with L. monocytogenes.  Wild type (WT), 881 
Stat1
 viable L. 878 
monocytogenes. Survival was monitored over 10 days. The study is representative of more than 879 
3 independent experiments. 880 
Y701F (YF) and Stat1-/- (S1) mice were infected by intraperitoneal injection of 1x 102
 889 
 viable L. 882 
monocytogenes. Number of colony forming units (CFU) in organs was determined at 48 h, 72 h 883 
or at the terminal stage of infection by plating homogenates on brain-heart-infusion (BHI) agar 884 
plates or Oxford agar plates (for lungs). Dots represent pooled data of 3 independent 885 
experiments. Lines represent the median and asterisks denote statistically significant 886 
differences (ns, p>0.05; *, p≤ 0.05; **, p≤ 0.01; ***, p≤ 0.001; ****, p≤ 0.0001); p-values were 887 
calculated using Mann-Whitney test. 888 
Figure 8 - Liver inflammation in Stat1Y701F and Stat1-/-
A Immunohistochemical analysis of infection and inflammatory infiltrates. Wild type 892 
(WT), Stat1
 mice after infection with Listeria 890 
monocytogenes. 891 
Y701F and Stat1-/- mice were infected by intraperitoneal injection of 1x102
B Quantitative evaluation of inflammatory infiltrates. Infiltrates representing the entire 897 
surface of sections from five animals per genotype were counted and categorized according to 898 
their size. 899 
 viable L. 893 
monocytogenes for 48 h. Liver sections were examined by immunohistochemistry with L. 894 
monocytogenes or Ly6C/Ly6G specific antibody. The scale bars on 20x magnification images 895 
represent 100 µm and 50 µm on the 63x magnification images. 896 
C Liver pathology in infected mice. Wild type (WT), Stat1Y701F (YF) and Stat1-/- (S1) mice 900 
were infected by intraperitoneal injection of 1x105 viable L. monocytogenes for 72 h. Serum was 901 
collected and tested for ALT activity. Lines represent the median and asterisks denote 902 
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statistically significant differences (*, p≤ 0.05; ***, p≤ 0.001); p-values were calculated using 903 
unpaired t-test. 904 
 905 
Table legend. 906 
 907 
Table 1: Transcriptome changes in macrophages of wt, Stat1Y701F and Stat1-/- genotypes after 908 
infection with L. monocytogenes. Numbers indicate differentially expressed genes between wt 909 
and Stat1Y701F macrophages (first row) and between STATY701F and Stat1-/-
Microarray data are deposited at ArrayExpress under accession number E-MTAB-3598 912 
(https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3598/). 913 
 macrophages 910 
(second row). Numbers in brackets indicate percent changes with respect to all genes analyzed. 911 
Expanded View Figure Legends: 914 
 915 
Figure EV1 - STAT1Y701F inhibits late STAT1-independent, STAT2/IRF9-dependent ISG 916 
expression in response to IFNβ. 917 
A Expression of Stat1 and Stat2 genes. Bone marrow derived macrophages (BMDMs) of 918 
wild type (WT), Stat1Y701F and Stat1-/-
B Expression of type I IFN-induced genes. BMDMs of wild type (WT), Stat1
 mice were treated with 5 ng/mL of IFNγ (IFNg) for 4 or 48 919 
h. Gene expression was measured by Q-PCR and normalized to Gapdh and to the expression 920 
levels in uninduced wild type cells.  921 
Y701F, Stat1-/-, 922 
Stat2-/- and IRF9-/-
The bars in A and B represent a mean value of 3 independent experiments. Error bars 926 
represent standard error of mean (SEM) and asterisks denote level of statistical significance 927 
(ns, p>0.05; *, p≤ 0.05; **, p≤ 0.01; ***, p≤ 0.001); the p-values were calculated using paired 928 
ratio t-test. 929 
 mice were treated with 250 IU/mL of IFNβ for 4 or 48 h. Gene expression was 923 
measured by Q-PCR and normalized to Gapdh and to the expression levels in uninduced wild 924 
type cells.  925 
 930 
Figure EV2 - Deletion of ISGF3 subunits or Stat1Y701F
Western blot analysis of STAT3 and STAT5 tyrosine phosphorylation. Bone marrow 933 
derived macrophages (BMDMs) of wild type (WT), Stat1
 mutation is without effect on the 931 
expression or IFNβ-stimulated phosphorylation of STAT3 and STAT5. 932 
Y701F (YF), Stat1-/- (S1), Stat2-/- (S2) and 934 
IRF9-/- (IRF9) mice were treated with 250 IU/mL of IFNβ for 0.5, 6, 12 or 24 h. The whole cell 935 
extracts were collected and tested in western blot for total STAT3 and STAT5 amounts and for 936 
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their tyrosine phosphorylation at, respectively, Y705 and Y694. The blots are representative of 937 
more than 3 independent experiments. 938 
 939 
Figure EV3 - STAT1Y701F mutant does not bind to ISRE sequences after IFNβ treatment. 940 
Genomic analysis of STAT1 binding. ChIP-seq analysis was performed on bone marrow 941 
derived macrophages (BMDMs) of wild type (WT), Stat1Y701F (YF) and Stat1-/- (S1) mice. 942 
BMDMs were 943 
treated with 944 
250 IU/mL of 945 
IFNβ (IFNb) 946 
for 2 h. Chromatin immunoprecipitation (ChIP) was performed using STAT1 antibody. 4 genes 947 
are shown as representative examples. A genome-wide search did not produce evidence of 948 
STAT1Y701F binding to ISREs elsewhere in the genome. ChIP-Seq data are deposited at 949 
ArrayExpress under accession number E-MTAB-3597 950 
(https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3597/). 951 
 952 
Figure EV4 - Immune cells infiltrates in Stat1Y701F mice livers are smaller in numbers and 953 
size compared to Stat1-/-
Wild type (WT), Stat1
 livers. These infiltrates are mostly composed of F4/80-negative 954 
cells. 955 
Y701F and Stat1-/- mice were infected by intraperitoneal injection of 956 
1x102 
 960 
L. monocytogenes for 48 h. Immunohistochemistry was performed on liver sections using 957 
F4/80-specific antibody. The scale bars on 20x magnification images represent 100 µm and 50 958 
µm on the 63x magnification images. 959 
Table 1. Microarray analysis of L. monocytogenes-infected macrophages from Wt, Stat1Y701F
 
 961 
and Stat1-/- mice.  962 
untreated 6 h 12 h 24 h 
WT 6 (0.08%) 1047 (13.68%) 570 (7.46%) 274 (3.58%) 
Stat1 0 -/- 0 0 0 
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Table 1. Microarray analysis of L. monocytogenes-infected macrophages from Wt, 
Stat1Y701F and Stat1-/- mice. 
 untreated 6 h 12 h 24 h 
WT 6 (0.08%) 1047 (13.68%) 570 (7.46%) 274 (3.58%) 
Stat1-/- 0 0 0 0 
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